Covered recipient · General Payments record
USMAN ASHRAF
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$1,151.81
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $553.82 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $281.00 | 14 |
| Otsuka America Pharmaceutical, Inc. | $120.83 | 1 |
| Merz Pharmaceuticals, LLC | $114.68 | 3 |
| TRICE MEDICAL, INC. | $37.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.02 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246869 | CMS |
| ABBVIE INC. | $17.77 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246871 | CMS |
| ABBVIE INC. | $23.14 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246873 | CMS |
| ABBVIE INC. | $17.33 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246875 | CMS |
| ABBVIE INC. | $25.45 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246877 | CMS |
| ABBVIE INC. | $17.61 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246879 | CMS |
| ABBVIE INC. | $21.03 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246881 | CMS |
| ABBVIE INC. | $19.53 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246883 | CMS |
| ABBVIE INC. | $27.20 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246885 | CMS |
| ABBVIE INC. | $24.84 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246887 | CMS |
| ABBVIE INC. | $20.59 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246889 | CMS |
| ABBVIE INC. | $19.15 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246891 | CMS |
| ABBVIE INC. | $7.31 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246893 | CMS |
| ABBVIE INC. | $19.03 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246895 | CMS |
| Merz Pharmaceuticals, LLC | $34.54 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137955665 | CMS |
| Merz Pharmaceuticals, LLC | $39.02 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137955667 | CMS |
| Merz Pharmaceuticals, LLC | $41.12 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137955669 | CMS |
| Otsuka America Pharmaceutical, Inc. | $120.83 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118855617 | CMS |
| TRICE MEDICAL, INC. | $37.31 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128532537 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.